Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. United States In-Vitro Diagnostics (IVD) Market


6. Market Share – United States In-Vitro Diagnostics (IVD) Analysis

6.1 By Test Types
6.2 By Products
6.3 By Application


7. Test Types – United States In-Vitro Diagnostics (IVD) Market

7.1 ELISA & CLIA
7.2 PCR
7.3 Rapid Test
7.4 Fluorescence Immunoassays (FIA)
7.5 In Situ Hybridization
7.6 Transcription Mediated Amplification
7.7 Sequencing
7.8 Colorimetric Immunoassay
7.9 Radioimmunoassay (RIA)
7.10 Isothermal Nucleic Acid Amplification Technology
7.11 Others


8. Products – United States In-Vitro Diagnostics (IVD) Market

8.1 Reagents
8.2 Instruments
8.3 Services


9. Application – United States In-Vitro Diagnostics (IVD) Market

9.1 Immunochemistry
9.2 Clinical Chemistry
9.3 Hematology
9.4 Coagulation
9.5 Molecular Diagnostics
9.6 Microbiology
9.7 Others


10. Porter’s Five Forces Analysis – United States In-Vitro Diagnostics (IVD) Market

10.1 Threat of New Entry
10.2 The Bargaining Power of Buyer
10.3 Threat of Substitution
10.4 The Bargaining Power of Supplier
10.5 Competitive Rivalry


11. SWOT Analysis – United States In-Vitro Diagnostics (IVD) Market

11.1 Strengths
11.2 Weaknesses
11.3 Opportunities
11.4 Threats


12. Company Analysis

12.1 Roche Diagnostics

12.1.1 Overview
12.1.2 Recent Development
12.1.3 Revenue

12.2 Danaher Corporation

12.2.1 Overview
12.2.2 Recent Development
12.2.3 Revenue

12.3 Thermofisher Scientific Inc.

12.3.1 Overview
12.3.2 Recent Development
12.3.3 Revenue

12.4 Bio–Rad Laboratories, Inc

12.4.1 Overview
12.4.2 Recent Development
12.4.3 Revenue

12.5 Biomerieux

12.5.1 Overview
12.5.2 Recent Development
12.5.3 Revenue

12.6 Abbott Laboratories

12.6.1 Overview
12.6.2 Recent Development
12.6.3 Revenue

12.7 Sysmex Corporation

12.7.1 Overview
12.7.2 Recent Development
12.7.3 Revenue



List of Figures

Figure-01: United States – In-Vitro Diagnostics (IVD) Market (Billion US$), 2019 – 2023
Figure-02: United States – Forecast for In-Vitro Diagnostics (IVD) Market (Billion US$), 2024 – 2030
Figure-03: Test Type – ELISA & CLIA Market (Million US$), 2019 – 2023
Figure-04: Test Type – Forecast for ELISA & CLIA Market (Million US$), 2024 – 2030
Figure-05: Test Type – PCR Market (Million US$), 2019 – 2023
Figure-06: Test Type – Forecast for PCR Market (Million US$), 2024 – 2030
Figure-07: Test Type – Rapid Test Market (Million US$), 2019 – 2023
Figure-08: Test Type – Forecast for Rapid Test Market (Million US$), 2024 – 2030
Figure-09: Test Type – Fluorescence Immunoassays (FIA) Market (Million US$), 2019 – 2023
Figure-10: Test Type – Forecast for Fluorescence Immunoassays (FIA) Market (Million US$), 2024 – 2030
Figure-11: Test Type – In Situ Hybridization Market (Million US$), 2019 – 2023
Figure-12: Test Type – Forecast for In Situ Hybridization Market (Million US$), 2024 – 2030
Figure-13: Test Type – Transcription Mediated Amplification Market (Million US$), 2019 – 2023
Figure-14: Test Type – Forecast for Transcription Mediated Amplification Market (Million US$), 2024 – 2030
Figure-15: Test Type – Sequencing Market (Million US$), 2019 – 2023
Figure-16: Test Type – Forecast for Sequencing Market (Million US$), 2024 – 2030
Figure-17: Test Type – Colorimetric Immunoassay Market (Million US$), 2019 – 2023
Figure-18: Test Type – Forecast for Colorimetric Immunoassay Market (Million US$), 2024 – 2030
Figure-19: Test Type – Radioimmunoassay (RIA) Market (Million US$), 2019 – 2023
Figure-20: Test Type – Forecast for Radioimmunoassay (RIA) Market (Million US$), 2024 – 2030
Figure-21: Test Type – Isothermal Nucleic Acid Amplification Technology Market (Million US$), 2019 – 2023
Figure-22: Test Type – Forecast for Isothermal Nucleic Acid Amplification Technology Market (Million US$), 2024 – 2030
Figure-23: Test Type – Others Market (Million US$), 2019 – 2023
Figure-24: Test Type – Forecast for Others Market (Million US$), 2024 – 2030
Figure-25: Products – Reagents Market (Million US$), 2019 – 2023
Figure-26: Products – Forecast for Reagents Market (Million US$), 2024 – 2030
Figure-27: Products – Instruments Market (Million US$), 2019 – 2023
Figure-28: Products – Forecast for Instruments Market (Million US$), 2024 – 2030
Figure-29: Products – Services Market (Million US$), 2019 – 2023
Figure-30: Products – Forecast for Services Market (Million US$), 2024 – 2030
Figure-31: Application – Immunochemistry Market (Million US$), 2019 – 2023
Figure-32: Application – Forecast for Immunochemistry Market (Million US$), 2024 – 2030
Figure-33: Application – Clinical Chemistry Market (Million US$), 2019 – 2023
Figure-34: Application – Forecast for Clinical Chemistry Market (Million US$), 2024 – 2030
Figure-35: Application – Hematology Market (Million US$), 2019 – 2023
Figure-36: Application – Forecast for Hematology Market (Million US$), 2024 – 2030
Figure-37: Application – Coagulation Market (Million US$), 2019 – 2023
Figure-38: Application – Forecast for Coagulation Market (Million US$), 2024 – 2030
Figure-39: Application – Molecular Diagnostics Market (Million US$), 2019 – 2023
Figure-40: Application – Forecast for Molecular Diagnostics Market (Million US$), 2024 – 2030
Figure-41: Application – Microbiology Market (Million US$), 2019 – 2023
Figure-42: Application – Forecast for Microbiology Market (Million US$), 2024 – 2030
Figure-43: Application – Others Market (Million US$), 2019 – 2023
Figure-44: Application – Forecast for Others Market (Million US$), 2024 – 2030
Figure-45: Roche Diagnostics – Global Revenue (Million US$), 2019 – 2023
Figure-46: Roche Diagnostics – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-47: Danaher Corporation – Global Revenue (Million US$), 2019 – 2023
Figure-48: Danaher Corporation – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-49: Thermofisher Scientific Inc. – Global Revenue (Million US$), 2019 – 2023
Figure-50: Thermofisher Scientific Inc. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-51: Bio–Rad Laboratories, Inc – Global Revenue (Million US$), 2019 – 2023
Figure-52: Bio–Rad Laboratories, Inc – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-53: Biomerieux – Global Revenue (Million US$), 2019 – 2023
Figure-54: Biomerieux – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-55: Abbott Laboratories – Global Revenue (Million US$), 2019 – 2023
Figure-56: Abbott Laboratories – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-57: Sysmex Corporation – Global Revenue (Million US$), 2019 – 2023
Figure-58: Sysmex Corporation – Forecast for Global Revenue (Million US$), 2024 – 2030

List of Tables

Table-01: United States – In-Vitro Diagnostics Market Share by Test Type (Percent), 2019 – 2023
Table-02: United States – Forecast for In-Vitro Diagnostics Market Share by Test Type (Percent), 2024 – 2030
Table-03: United States – In-Vitro Diagnostics Market Share by Product (Percent), 2019 – 2023
Table-04: United States – Forecast for In-Vitro Diagnostics Market Share by Product (Percent), 2024 – 2030
Table-05: United States – In-Vitro Diagnostics Market Share by Application (Percent), 2019 – 2023
Table-06: United States – Forecast for In-Vitro Diagnostics Market Share by Application (Percent), 2024 – 2030